A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.
Van Hoeven N, Fox CB, Granger B, Evers T, Joshi SW, Nana GI, Evans SC, Lin S, Liang H, Liang L, Nakajima R, Felgner PL, Bowen RA, Marlenee N, Hartwig A, Baldwin SL, Coler RN, Tomai M, Elvecrog J, Reed SG, Carter D.
Van Hoeven N, et al. Among authors: elvecrog j.
Sci Rep. 2017 Apr 21;7:46426. doi: 10.1038/srep46426.
Sci Rep. 2017.
PMID: 28429728
Free PMC article.